| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/2010 | US20100234299 Stable formulation of modified glp-1 |
| 09/16/2010 | US20100234298 Matrix protein compositions for induction of apoptosis |
| 09/16/2010 | US20100234297 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health |
| 09/16/2010 | US20100234296 Food material for inhibiting osteoclastogenesis |
| 09/16/2010 | US20100234295 Treating Alzheimer's Disease And Osteoporosis And Reducing Aging |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234292 Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer |
| 09/16/2010 | US20100234291 Preparation and use of low-bleeding anticoagulant fusion protein |
| 09/16/2010 | US20100234290 Stabilized Insulin-like Growth Factor Polypeptides |
| 09/16/2010 | US20100234289 Integrin binding rgd-lipopeptides with gene transfer activities |
| 09/16/2010 | US20100234288 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION ON THE BASIS OF RELEASE SYSTEM COMPRISING AN ACID-SOLUBLE POLYMER AND A pH-DEPENDENT POLYMER |
| 09/16/2010 | US20100234287 Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics |
| 09/16/2010 | US20100234286 Preterm formula |
| 09/16/2010 | US20100234285 Benzofuranyl Derivatives |
| 09/16/2010 | US20100234284 Pharmaceutical compositions based on NK2 antagonists for pediatric use |
| 09/16/2010 | US20100234283 Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| 09/16/2010 | US20100234282 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 09/16/2010 | US20100234281 Antibacterial antisense oligonucleotide and method |
| 09/16/2010 | US20100234280 Antisense antibacterial method and compound |
| 09/16/2010 | US20100234279 Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| 09/16/2010 | US20100234278 Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 09/16/2010 | US20100234277 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 09/16/2010 | US20100234276 Erythropoietin solution preparation |
| 09/16/2010 | US20100234275 Use Of A High Molecular Weight Extracellular Hemoglobin For The Manufacture Of A Medicament For Treating And/Or Preventing Diseases By Inhibition Of Calcium |
| 09/16/2010 | US20100234274 Use of Nestafin-1 in the Treatment for Diabetes |
| 09/16/2010 | US20100234273 Light-activated cation channel and uses thereof |
| 09/16/2010 | US20100234272 Processes for Preparing a Polypeptide |
| 09/16/2010 | US20100234219 Isoxazolines for Controlling Invertebrate Pests |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/16/2010 | US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 09/16/2010 | US20100233304 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| 09/16/2010 | US20100233302 The use of a vegf binding peptide to retard hair growth |
| 09/16/2010 | US20100233297 Systemic administration of nac as an adjunct in the treatment of terrorism exposures such as radiation and for prophylaxis |
| 09/16/2010 | US20100233295 Aqueous moisturizers and lubricants and uses thereof |
| 09/16/2010 | US20100233277 Biodegradable polymer scaffold and process for preparation thereof |
| 09/16/2010 | US20100233274 Means and methods for enhancing weight gain in poultry |
| 09/16/2010 | US20100233267 Composite hydrogel |
| 09/16/2010 | US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF |
| 09/16/2010 | US20100233262 Coated tablet |
| 09/16/2010 | US20100233249 Contraceptive methods and compositions related to proteasomal interference |
| 09/16/2010 | US20100233246 Adhesive tissue repair patch and collagen sheets |
| 09/16/2010 | US20100233242 Engineered proteins, and methods of making and using |
| 09/16/2010 | US20100233241 Ophthalmic drug delivery system and applications |
| 09/16/2010 | US20100233238 Medical Devices Having Nanoporous Coatings for Controlled Therapeutic Agent Delivery |
| 09/16/2010 | US20100233234 System and method for a hydrogel and hydrogel composite for cartilage repair applications |
| 09/16/2010 | US20100233232 Fatty-acid based particles |
| 09/16/2010 | US20100233231 Use of cryogenic processing to obtain a substantially-thickened formulation |
| 09/16/2010 | US20100233229 In-vivo indwelling device |
| 09/16/2010 | US20100233226 Drug-eluting nanowire array |
| 09/16/2010 | US20100233225 Method of surface coating devices to incorporate bioactive molecules |
| 09/16/2010 | US20100233218 Combination enzyme for cystic fibrosis |
| 09/16/2010 | US20100233205 Adjuvanted antigenic meningococcal compositions |
| 09/16/2010 | US20100233194 Treatment of neovascular ocular disease states |
| 09/16/2010 | US20100233193 Systemic administration of nac for vaccination prophylaxis |
| 09/16/2010 | US20100233191 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233185 Caries Risk Test for Predicting and Assessing the Risk of Disease |
| 09/16/2010 | US20100233179 BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 09/16/2010 | US20100233172 Methods of inhibiting quiescent tumor proliferation |
| 09/16/2010 | US20100233171 Differential Drug Sensitivity |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233161 Novel multifunctional compounds for pharmaceutical purposes |
| 09/16/2010 | US20100233152 Use of HMGB proteins and nucleic acids that code therefor |
| 09/16/2010 | US20100233151 Compositions and methods for treating collagen-mediated diseases |
| 09/16/2010 | US20100233150 Supplying collagenase, protease to tissue; for removing excess amounts of unaesthetic and/or redundant subcutaneous adipose tissue; lipomas |
| 09/16/2010 | US20100233149 Methods for preparing Factor X, activated Factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same |
| 09/16/2010 | US20100233148 Injection of fibrin sealant including an anesthetic in spinal applications |
| 09/16/2010 | US20100233147 Method and apparatus for thrombus removal using magnetic particles |
| 09/16/2010 | US20100233135 Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| 09/16/2010 | US20100233127 Targeted vectors for cancer immunotherapy |
| 09/16/2010 | US20100233123 Phosphothiophene and phosphothiazole hcv polymerase inhibitors |
| 09/16/2010 | US20100233122 Novel benzimidazole derivatives |
| 09/16/2010 | US20100233121 Method for treating multiple sclerosis |
| 09/16/2010 | US20100233120 Hepatitis C Virus Inhibitors |
| 09/16/2010 | US20100233119 Suppression of immune response to factor viii in hemophilia a patients |
| 09/16/2010 | US20100233118 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
| 09/16/2010 | US20100233117 Adjuvant combination formulations |
| 09/16/2010 | US20100233116 Organic compounds |
| 09/16/2010 | US20100233111 Gastropod biological fluid, method of making and refining and use |
| 09/16/2010 | US20100233095 Conformationally dynamic peptides |
| 09/16/2010 | US20100233084 Method for Delivery Across the Blood Brain Barrier |
| 09/16/2010 | US20100233083 Microparticles comprising a crosslinked polymer |
| 09/16/2010 | DE102009047562A1 Agent comprises peptide compounds, useful for capturing or inhibiting avian influenza virus and in biosensor for detecting or capturing avian influenza virus |
| 09/16/2010 | DE102009012423A1 Zubereitung auf Ölbasis Preparation oil-based |
| 09/16/2010 | CA2787849A1 Injectable biomaterials |
| 09/16/2010 | CA2755473A1 Treatment of diseases related to hyperactivity of the complement system |
| 09/16/2010 | CA2755396A1 Use of hasf as a protective agent against ischemic tissue damage |
| 09/16/2010 | CA2755116A1 Ameliorating agent for chronic obstructive pulmonary disease |
| 09/16/2010 | CA2755068A1 Treatment of diabetes and metabolic syndrome |
| 09/16/2010 | CA2755047A1 Treatment methods for autoimmune disorders |
| 09/16/2010 | CA2754961A1 Treatment and diagnostic methods for hypersensitive disorders |
| 09/16/2010 | CA2754623A1 Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
| 09/16/2010 | CA2754604A1 Compositions and methods for elimination of gram-negative bacteria |
| 09/16/2010 | CA2754056A1 Mirac proteins |
| 09/16/2010 | CA2753871A1 Immunomodulatory therapeutic agents |
| 09/16/2010 | CA2753824A1 Methods for the treatment or prevention of systemic sclerosis |
| 09/16/2010 | CA2753282A1 Use of serine protease inhibitors in the treatment of neutropenia |
| 09/15/2010 | EP2228448A1 MU-1 member of the cytokine receptor family |